Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$4.76B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.4B |
| 4 |
Amazon
AMZN
|
+$1.22B |
| 5 |
Broadcom
AVGO
|
+$1.21B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$150M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$110M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3051
TaskUs
TASK
$1.56B
| $2.52M | ﹤0.01% |
195,156
-23,692
| -11% | -$306K |
|
3052
Hagerty
HGTY
$1.24B
| $2.52M | ﹤0.01% |
247,449
-9,271
| -4% | -$94.4K |
|
3053
D-Wave Quantum
QBTS
$6.07B
| $2.51M | ﹤0.01% |
2,555,927
+645,039
| +34% | +$634K |
|
3054
uniQure
QURE
$904M
| $2.51M | ﹤0.01% |
508,602
+6,362
| +1% | +$31.4K |
|
3055
Tenaya Therapeutics
TNYA
$196M
| $2.5M | ﹤0.01% |
1,296,156
+66,968
| +5% | +$129K |
|
3056
Sonida Senior Living
SNDA
$500M
| $2.5M | ﹤0.01% |
93,430
-14,683
| -14% | -$393K |
|
3057
Alvotech
ALVO
$2.5B
| $2.49M | ﹤0.01% |
209,257
+21,022
| +11% | +$250K |
|
3058
Cardiff Oncology
CRDF
$136M
| $2.48M | ﹤0.01% |
928,232
+17,557
| +2% | +$46.9K |
|
3059
SoundThinking
SSTI
$160M
| $2.48M | ﹤0.01% |
213,574
-2,758
| -1% | -$32K |
|
|
CTNM
3060
Contineum Therapeutics
CTNM
$347M
| $2.46M | ﹤0.01% |
128,676
-27,745
| -18% | -$531K |
|
3061
Harvard Bioscience
HBIO
$19.7M
| $2.46M | ﹤0.01% |
912,599
+19,972
| +2% | +$53.7K |
|
3062
Everspin Technologies
MRAM
$154M
| $2.44M | ﹤0.01% |
412,879
+1,941
| +0.5% | +$11.5K |
|
3063
NACCO Industries
NC
$297M
| $2.43M | ﹤0.01% |
85,852
-6,975
| -8% | -$198K |
|
|
BLUE
3064
DELISTED
bluebird bio
BLUE
| $2.43M | ﹤0.01% |
234,152
+8,338
| +4% | +$86.6K |
|
|
NKLA
3065
DELISTED
Nikola Corporation Common Stock
NKLA
| $2.4M | ﹤0.01% |
524,731
+53,966
| +11% | +$247K |
|
3066
Rezolute
RZLT
$669M
| $2.39M | ﹤0.01% |
491,601
+137,905
| +39% | +$669K |
|
3067
Galectin Therapeutics
GALT
$344M
| $2.37M | ﹤0.01% |
862,542
+20,817
| +2% | +$57.3K |
|
3068
IBEX
IBEX
$556M
| $2.35M | ﹤0.01% |
117,831
+76
| +0.1% | +$1.52K |
|
|
VRN
3069
DELISTED
Veren
VRN
| $2.35M | ﹤0.01% |
380,386
+15,594
| +4% | +$96.4K |
|
3070
QuickLogic
QUIK
$92.3M
| $2.35M | ﹤0.01% |
306,267
-5,449
| -2% | -$41.8K |
|
3071
Ramaco Resources Class B
METCB
$1.04B
| $2.34M | ﹤0.01% |
222,650
-37,689
| -14% | -$396K |
|
3072
Puma Biotechnology
PBYI
$225M
| $2.34M | ﹤0.01% |
917,367
-32,779
| -3% | -$83.6K |
|
3073
eGain
EGAN
$220M
| $2.33M | ﹤0.01% |
457,783
-10,308
| -2% | -$52.6K |
|
|
QVCGA
3074
QVC Group, Inc. Series A Common Stock
QVCGA
$92M
| $2.33M | ﹤0.01% |
76,499
+3,362
| +5% | +$103K |
|
3075
Marine Products Corp
MPX
$316M
| $2.33M | ﹤0.01% |
240,735
+8,527
| +4% | +$82.6K |
|